Manlio Ferrarini Selected Research

B-Cell Antigen Receptors (B Cell Antigen Receptors)

1/2022	Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements.
3/2008	Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
4/2004	Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.
1/2003	B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manlio Ferrarini Research Topics

Disease

44	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 03/2002
9	Neoplasms (Cancer) 01/2021 - 05/2010
5	Disease Progression 01/2021 - 08/2014
3	Trisomy (Trisomies) 01/2020 - 08/2014
3	Lymphoma (Lymphomas) 01/2019 - 03/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2012 - 05/2010
2	Infections 01/2017 - 05/2011
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2014 - 09/2011
2	Multiple Myeloma 07/2013 - 11/2012
2	Lymphocytosis 01/2013 - 01/2008
2	Pathologic Complete Response 08/2012 - 05/2011
2	Leukemia 09/2011 - 01/2003
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2007 - 10/2003
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2017
1	Chromosomal Instability (Chromosome Stability) 07/2014
1	Bone Diseases (Bone Disease) 07/2013
1	Colorectal Neoplasms (Colorectal Cancer) 02/2013
1	Human Influenza (Influenza) 05/2011
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2009
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2009
1	Genetic Translocation (Chromosomal Translocation) 01/2007
1	Prolymphocytic Leukemia 01/2003
1	Residual Neoplasm 01/2003

Drug/Important Bio-Agent (IBA)

11	Biological ProductsIBA 03/2020 - 11/2007
7	Rituximab (Mabthera)FDA Link 04/2021 - 01/2003
6	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020 - 10/2003
5	MicroRNAs (MicroRNA)IBA 01/2015 - 11/2012
4	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 01/2022 - 01/2003
3	Immunoglobulins (Immunoglobulin)IBA 10/2020 - 01/2007
3	AntigensIBA 01/2019 - 06/2002
3	Biomarkers (Surrogate Marker)IBA 07/2014 - 01/2013
2	CytokinesIBA 10/2021 - 01/2008
2	ibrutinibIBA 04/2021 - 01/2021
2	Bendamustine Hydrochloride FDA Link 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2008
2	interleukin-21 (interleukin 21)IBA 01/2015 - 05/2010
2	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 02/2011
2	Influenza Vaccines (Influenza Vaccine)FDA Link 08/2012 - 05/2011
2	Immunoglobulin M (IgM)IBA 03/2008 - 03/2002
2	Peptide Nucleic AcidsIBA 01/2007 - 10/2003
2	Immunoglobulin Variable RegionIBA 11/2006 - 09/2002
2	Antigen Receptors (Antigen Receptor)IBA 08/2004 - 04/2004
1	Interleukin-23 (Interleukin 23)IBA 10/2022
1	Interleukin-11 (Interleukin 11)IBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	idelalisibIBA 04/2021
1	2,2- bis(hydroxymethyl)- 1- azabicyclo(2,2,2,)octan- 3- oneIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 03/2020
1	osimertinibIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2017
1	ferric oxide (iron oxide)IBA 11/2016
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 11/2016
1	betaglycan (TGFBR3)IBA 08/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2014
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2014
1	Proto-Oncogene Proteins c-metIBA 06/2014
1	mouse MIRN29 microRNAIBA 07/2013
1	ErbB Receptors (EGF Receptor)IBA 02/2013
1	locked nucleic acidIBA 02/2013
1	Monoclonal AntibodiesIBA 02/2013
1	VaccinesIBA 05/2011
1	Interleukin-2 (IL2)IBA 05/2010
1	InterleukinsIBA 05/2010
1	AntibodiesIBA 05/2010
1	Inosine Triphosphate (ITP)IBA 01/2009
1	B-Cell Activating FactorIBA 01/2009
1	AdiponectinIBA 11/2008
1	Tyrosine (L-Tyrosine)FDA Link 03/2008
1	Thrombopoietin (c-mpl Ligand)IBA 01/2008
1	Hemoglobins (Hemoglobin)IBA 01/2008
1	PNAEmu-NLSIBA 01/2007
1	Interleukin-21 ReceptorsIBA 05/2006
1	ElementsIBA 03/2006
1	Tocopherols (Tocopherol)IBA 10/2003
1	Alemtuzumab (Campath)FDA Link 01/2003
1	Surface Antigens (Surface Antigen)IBA 01/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2003
1	fludarabineIBA 01/2003
1	Immunoglobulin D (IgD)IBA 03/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 02/2011
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
1	Precision Medicine 11/2015
1	Ligation 09/2011
1	Aftercare (After-Treatment) 05/2011
1	Immunotherapy 01/2003